Overview
Human Cutaneous Lupus Erythematosus Serum for Research
Our Cutaneous Lupus Erythematosus Human Serum is sourced from IRB-consented donors clinically diagnosed with Cutaneous Lupus Erythematosus. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for disease-specific and immunological studies focused on cutaneous lupus erythematosus.
Product Features
- Collected from clinically confirmed Cutaneous Lupus Erythematosus donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
Donor Metadata
- Diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported medical history and comorbidities
Applications
- Biomarker discovery for cutaneous lupus erythematosus
- Serum cytokine and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Cutaneous Lupus Erythematosus serum is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.